3TND image
Deposition Date 2011-09-01
Release Date 2011-11-02
Last Version Date 2024-02-28
Entry Detail
PDB ID:
3TND
Title:
Crystal structure of Shigella flexneri VapBC toxin-antitoxin complex
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.70 Å
R-Value Free:
0.23
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 61 2 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:tRNA(fMet)-specific endonuclease VapC
Gene (Uniprot):vapC
Chain IDs:A, C, E, G
Chain Length:132
Number of Molecules:4
Biological Source:Shigella flexneri
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Antitoxin VapB
Gene (Uniprot):vapB
Chain IDs:B, D, F, H
Chain Length:81
Number of Molecules:4
Biological Source:Shigella flexneri
Primary Citation
Crystal Structure of the VapBC Toxin-Antitoxin Complex from Shigella flexneri Reveals a Hetero-Octameric DNA-Binding Assembly.
J.Mol.Biol. 414 713 722 (2011)
PMID: 22037005 DOI: 10.1016/j.jmb.2011.10.024

Abstact

Toxin-antitoxin (TA) loci are common in archaea and prokaryotes and allow cells to rapidly adapt to changing environmental conditions through release of active regulators of metabolism. Many toxins are endonucleases that target cellular mRNA and tRNAs, while the antitoxins tightly wrap around the toxins to inhibit them under normal circumstances. The antitoxins also bind to operators in the promoter regions of the cognate TA operon and thereby regulate transcription. For enteric vapBC TA loci, the VapC toxins specifically cleave tRNA(fMet) and thus down-regulate protein synthesis. Here, we describe the crystal structure of the intact Shigella flexneri VapBC TA complex, determined to 2.7 Å resolution. Both in solution and in the crystal structure, four molecules of each protein combine to form a large and globular hetero-octameric assembly with SpoVT/AbrB-type DNA-binding domains at each end and a total molecular mass of about 100 kDa. The structure gives new insights into the inhibition of VapC toxins by VapB and provides the molecular basis for understanding transcriptional regulation through VapB dimerization.

Legend

Protein

Chemical

Disease

Primary Citation of related structures